Cargando…
Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
Favipiravir (T-705), used against influenza viruses, is approved for emergency use in many countries for the treatment of COVID-19. The frequent adverse effects of favipiravir are related with the gastrointestinal system, however, studies suggest a positive association of favipiravir on QTc prolonga...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492396/ https://www.ncbi.nlm.nih.gov/pubmed/36152797 http://dx.doi.org/10.1016/j.toxlet.2022.09.011 |